Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kiel
Clinical trial register · Germany

Clinical Trials in Kiel, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5087 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:18 UTC
5087
Studies in scope
all four open statuses
2894
Recruiting now
open to new participants
991
Lead sponsors
across recruiting studies
Top sites
Berlin 39 Essen 26 Hamburg 22 Ulm 20 Dresden 18
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital Schleswig-Holstein14 AstraZeneca12 Sanofi9 Janssen Research & Development, LLC8 AbbVie7 University of Kiel7 Philogen S.p.A.5 Bristol-Myers Squibb5 Abbott Medical Devices5 Novartis Pharmaceuticals4 Pfizer4 Hoffmann-La Roche4 Gilead Sciences4 Incyte Corporation4 Takeda4 Longboard Pharmaceuticals3 German CLL Study Group3 Boston Scientific Corporation3 GlaxoSmithKline3 Amgen3 Novo Nordisk A/S3 Regeneron Pharmaceuticals3 Karyopharm Therapeutics Inc2 Abiomed Inc.2 UCB Biopharma SRL2 Merz Therapeutics GmbH2 argenx2 BeOne Medicines2 Assistance Publique - Hôpitaux de Paris2 Celgene2 University Hospital of Cologne2 Janssen-Cilag Ltd.2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Mirum Pharmaceuticals, Inc.2 Ipsen2 Replimune, Inc.2 Celldex Therapeutics2 InSightec2 Genmab2 University Hospital, Basel, Switzerland2 W.L.Gore & Associates1 Aarhus University Hospital Skejby1 University Hospital Freiburg1 The Lymphoma Academic Research Organisation1 Alliance Foundation Trials, LLC.1 Heidelberg University1 Marc Bosiers, MD1 University of Luebeck1 Prof. Dr. med. M.Sc. Georg Griesinger1 Merck Sharp & Dohme LLC1 Pierre Fabre Medicament1 Navigator Medicines, Inc.1 Infectopharm Arzneimittel GmbH1 Daiichi Sankyo1 Medtronic Cardiovascular1 Zogenix, Inc.1 Shape Memory Medical, Inc.1 CytoSorbents, Inc1 Alfasigma S.p.A.1 Cardiawave SA1 MMI (Medical Microinstruments, Inc.)1 University of Heidelberg Medical Center1 iVascular S.L.U.1 European Organisation for Research and Treatment of Cancer - EORTC1 Valentina Puentmann1 European Foundation for Study of Chronic Liver Failure1 Boehringer Ingelheim1 Spyre Therapeutics, Inc.1 MaaT Pharma1 Teva Branded Pharmaceutical Products R&D LLC1 Janssen Biotech, Inc.1 Cogent Biosciences, Inc.1 Stemline Therapeutics, Inc.1 Inari Medical1 LEO Pharma1 GCP-Service International West GmbH1 Prof. Dr. Stephan Weidinger1 Heidelberg Pharma AG1 Immunocore Ltd1 AgNovos Healthcare, LLC1 VDyne, Inc.1 Neuravi Limited1 Oruka Therapeutics, Inc.1 Universitätsklinikum Hamburg-Eppendorf1 AskBio Inc1 Goethe University1 Abivax S.A.1 Susanne Rogers1 Resilience1 Christian Buske1 AC Immune SA1 Wim Janssens1 Kartos Therapeutics, Inc.1 MicroPort CRM1 Tesaro, Inc.1 Technische Universität Dresden1 Steffen Paschen1 Artcline GmbH1 iSTAR Medical1 Citryll BV1 Hannover Medical School1 Research Center Borstel1 AnaptysBio, Inc.1 Seagen, a wholly owned subsidiary of Pfizer1 Evangelical Hospital Düsseldorf1 Tetec AG1 OncoZenge AB1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 Epizyme, Inc.1 Alexion Pharmaceuticals, Inc.1 University Hospital Heidelberg1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Children's Oncology Group1 Intressa Vascular SA1 Waldemar Link GmbH & Co. KG1 Galderma R&D1 Loxo Oncology, Inc.1 Guerbet1 Priovant Therapeutics, Inc.1 OncoVerity, Inc.1 CSL Behring1 Olema Oncology, Inc.1 Alimentiv Inc.1 MediWound Ltd1 Clear sponsor filter
Target enrolment
to

Trials with a site in Kiel

4 of 5087 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Hoffmann-La Roche
Phase 2
45
Nuremberg, Greifswald, Heidelberg, Jena, Kiel
2026-11-03
Recruiting
Hoffmann-La Roche
Phase 3
380
Bad Saarow, Berlin, Düsseldorf, Frankfurt, Greifswald, Hamburg, Kiel
2026-06-23
Active, closed
Hoffmann-La Roche
Phase 3
746
Berlin, Böblingen, Dresden, Giessen, Kiel, Stuttgart, Tübingen, Ulm
2021-03-17
Active, closed
Hoffmann-La Roche
Phase 3
864
Berlin, Bochum, Dresden, Kiel, Leipzig, Ulm, Wiesbaden
2020-11-26
Rows per page Showing 1–4 of 4
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-germany/city/kiel

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,087 studies in total at the last sync on 20 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 4 of those studies with a site in Kiel that also match the filters currently applied.

How many clinical trials are recruiting in Kiel?

2 of the 4 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kiel), 4 studies
PhaseStudiesRecruitingShare
Phase 33175%
Phase 21125%

Most active sponsors

Lead sponsors with the most studies (Kiel)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche42
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.